whatshot

GNGBF   $18.5  -18.39% Market Closed

GETINGE AB SHS B
show_chart Advanced Chart of GNGBF
Last Events:

2022-11-22 Trend pattern changed from расширяющаяся формация to канал.

2022-11-22 Signal in RSI changed from bullish reversal to bearish recovery. RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

2022-11-21 Trend pattern changed from расходящийся клин с наклоном вверх to расширяющаяся формация.

2022-11-21 Signal in Stochastic changed from bearish recovery to bullish. The stochastic indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: up-crossing the middle level.

2022-11-21 Signal in MACD changed from bearish to bearish weakening. Oscillator MACD is in the negative territory it's lower than the signal line and grows. These factors mean that the falling trend persists, but the growth rate is declining. Last signal: entry into the oversold zone.

2022-11-21 Signal in RSI changed from bearish recovery to bullish reversal. RSI indicator is in the lower part of the neutral territory and it grows. These factors indicate that the upside trend is confirmed. Last signal: exit from the overbought zone.

2022-11-21 Trend Power changed from to slow.

2022-11-21 Trend changed from up and flat to turning down.

Current temperature: 0.00
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 8
Target Price Mean 26.33
Mean unverified/preliminary 26.33 / 26.33
Target Price Low / High 23.90 / 29.88
Median / STD DEV 25.65 / 22.90
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Buy ActivelyBuy -
rsi Sell ActivelyBuy -
macd - - -
stoch Buy ActivelyBuy -
ma20 Sell - -
ma50 Sell - -
ma100 Sell - -
ISIN SE0000202624
ceo Mr. Mattias Perjos M.Sc.
Website https://www.getinge.com
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.